APA (7th ed.) Citation

E, M., M, Z., M, K., LR, B., D, F., A, M., . . . SB, G. (2025). Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate. The New England journal of medicine, 393(18), 1807. https://doi.org/10.1056/NEJMoa2501073

Chicago Style (17th ed.) Citation

E, Malkin, et al. "Safety and Immunogenicity of an RVSV Lassa Fever Vaccine Candidate." The New England Journal of Medicine 393, no. 18 (2025): 1807. https://doi.org/10.1056/NEJMoa2501073.

MLA (9th ed.) Citation

E, Malkin, et al. "Safety and Immunogenicity of an RVSV Lassa Fever Vaccine Candidate." The New England Journal of Medicine, vol. 393, no. 18, 2025, p. 1807, https://doi.org/10.1056/NEJMoa2501073.